Other class III agents

Because of the increased use of amiodarone as a broad-spectrum antiarrhythmic agent there has been much interest in developing new class III agents without the side-effect profile of amiodarone in chronic use. Sotalol, a racemic mixture of D- and L-sotalol, is perhaps the most widely used but is limited by significant b-blocking activity. D-Sotalol has minimal b-blocking activity but has proved unsuccessful in the setting of high-risk postmyocardial infarction patients, with excess mortality in those taking active drug. Other agents such as dofetilide and ibutilide remain in development, but their ultimate clinical role remains to be determined.

Kicking Fear And Anxiety To The Curb

Kicking Fear And Anxiety To The Curb

Kicking Fear And Anxiety To The Curb Can Have Amazing Benefits For Your Life And Success. Learn About Calming Down And Gain Power By Learning Ways To Become Peaceful And Create Amazing Results.

Get My Free Ebook


Post a comment